English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51828728    ???header.onlineuser??? :  790
???header.sponsordeclaration???
 		 
???search.scope??? ???search.advance???
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???
???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
Repositories
Author
Title
Date
???ui.leftmenu.statisticschart???
???ui.leftmenu.realtimefacts???
???ui.leftmenu.trend???

???index.news???
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

???ui.leftmenu.copyrighttitle???
???ui.leftmenu.copyrightpublisher???
???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
???tair.name??? >  ???browser.page.title.author???

"wu j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 291-300 of 599  (60 Page(s) Totally)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-08-13T06:34:02Z Leg pains, clubbing of digits and lung mass: What is your call? Wu J.-Y.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:34:00Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH; Wei P.-F.; Hsu Y.-C.; Chang Y.-C.; Gow C.-H.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.
臺大學術典藏 2020-08-13T06:33:58Z Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer JIN-YUAN SHIH; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; Yang P.-C.; Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Yang P.-C.
臺大學術典藏 2020-08-13T06:33:57Z Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; JIN-YUAN SHIH; Yang P.-C.; Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Jin-Yuan Shih;Yang P.-C.
臺大學術典藏 2020-08-13T06:33:53Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.; Yang P.-C.; JIN-YUAN SHIH; Chen K.-Y.; Yang C.-H.; Yu C.-J.
臺大學術典藏 2020-08-13T06:33:53Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:52Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:38Z Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer JIN-YUAN SHIH; Wu J.-Y.
臺大學術典藏 2020-08-13T06:33:25Z Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations Wu J.-Y.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏 2020-08-12T08:25:31Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang C.-H.; SHANG-GIN WU; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.

Showing items 291-300 of 599  (60 Page(s) Totally)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
View [10|25|50] records per page

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team